$AMRN Headlines Expedia falls on Google penalt
Post# of 94265
Posted On: 05/15/2014 12:04:35 PM
$AMRN Headlines
Expedia falls on Google penalty; Alcoa jumps on upgrade 4:54 p.m. Jan. 21, 2014 - Sue Chang
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 5:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Intercept, Celgene on move amid J.P. Morgan event 10:20 a.m. Jan. 13, 2014 - Victor Reklaitis
6 gut checks before the stock market's opening bell 7:12 a.m. July 8, 2013 - Shawn Langlois
6 gut checks before the stock market's opening bell 7:55 a.m. March 27, 2013 - Shawn Langlois
7 gut checks before the stock market's opening bell 8:05 a.m. Feb. 27, 2013 - Shawn Langlois
Friday’s big movers: Groupon soars on Google talk 5:38 p.m. Dec. 7, 2012 - Sue Chang
Amarin down 17% on risks tied to drug launch 9:00 a.m. Dec. 7, 2012 - Steve Gelsi
Amarin down 18% in premarket trades 8:41 a.m. Dec. 7, 2012 - Steve Gelsi
Wednesday’s biggest gaining and declining stocks 4:40 p.m. Oct. 10, 2012 - Sue Chang
Tuesday’s top gaining and declining stocks 4:57 p.m. Sept. 11, 2012 - MarketWatch
Amarin issues patent update on fish-oil drug 12:29 p.m. Sept. 5, 2012 - Val Brickates Kennedy
Amarin jumps 16% after business update 12:06 p.m. Aug. 9, 2012 - Val Brickates Kennedy
Amarin rallies 15% on business update 10:48 a.m. Aug. 9, 2012 - Val Brickates Kennedy
Amarin falls 11% on insider stock-sale reports 12:12 p.m. July 31, 2012 - Val Brickates Kennedy
Amarin, AuthenTec active; advancers outpace decliners 4-1 on NYSE 12:45 p.m. July 27, 2012 - blogs.marketwatch.com
Amarin down 9% in wake of drug approval 10:08 a.m. July 27, 2012 - Val Brickates Kennedy
Amarin gets FDA approval for Vascepa 6:09 p.m. July 26, 2012 - Wallace Witkowski
Amarin: FDA OKs Vascepa for high triglycerides 5:46 p.m. July 26, 2012 - Wallace Witkowski
Amarin halted ahead of FDA decision deadline 3:13 p.m. July 26, 2012 - Val Brickates Kennedy
Top Analyst Upgrades and Downgrades: Amarin, Boeing, Cisco, KKR, NetApp, Twitter and More 8:01 a.m. May 12, 2014 - 247WallSt.com
Amarin's (AMRN) CEO John Thero on Q1 2014 Results - Earnings Call Transcript 12:20 p.m. May 9, 2014 - Seeking Alpha
More on Amarin Q1 results 7:37 a.m. May 9, 2014 - Seeking Alpha
10-Q: AMARIN CORP PLC\UK 7:10 a.m. May 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
Move over Vascepa, here comes Epanova 7:08 a.m. May 6, 2014 - Seeking Alpha
Amarin Takes Step 1, Of A Million, To Right Its Ship 3:21 p.m. April 1, 2014 - Seeking Alpha
Amarin: How The Co-Promotion Agreement With Kowa Affects Required Sales Targets 12:53 a.m. April 1, 2014 - Seeking Alpha
Amarin +4.4% AH on U.S. Vascepa co-promotion deal 5:03 p.m. March 31, 2014 - Seeking Alpha
Looking For Value Among Biotechs After Precipitous Declines In Stock Price 12:26 p.m. March 24, 2014 - Seeking Alpha
Biotech Stock Mailbag: Amarin, Cytrx, Sangamo and 'Story Stocks' 7:00 a.m. March 21, 2014 - TheStreet.com
Are Biotech Stocks Located in Ireland Top Buyout Candidates? 9:34 a.m. March 19, 2014 - 247WallSt.com
Amarin Management Discusses Q4 2013 Results - Earnings Call Transcript 10:20 p.m. Feb. 27, 2014 - Seeking Alpha
10-K: AMARIN CORP PLC\UK 4:14 p.m. Feb. 27, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notable earnings after Thursday’s close 5:35 p.m. Feb. 26, 2014 - Seeking Alpha
Amarin Is Likely Now A Vortex Where Your Money Will Go To Die 2:16 p.m. Feb. 26, 2014 - Seeking Alpha
What Now For Amarin? 2:54 p.m. Feb. 25, 2014 - Seeking Alpha
Amarin's Vascepa Gets 3-Year Exclusivity - Analyst Blog 5:20 p.m. Feb. 24, 2014 - Zacks.com
Amarin fair value target cut at MKM after FDA decision 3:16 p.m. Feb. 24, 2014 - Seeking Alpha
Amarin Loses Bid for Vascepa 5-Year Market Exclusivity 7:59 a.m. Feb. 24, 2014 - TheStreet.com
Amarin's Vascepa given marketing exclusivity, shares +4.8% AH 4:22 p.m. Feb. 21, 2014 - Seeking Alpha
Amarin Announces Private Exchange Transactions Regarding Outstanding Senior Exchangeable Notes 5:00 a.m. Today - GlobeNewswire
Amarin Reports First Quarter 2014 Financial Results and Provides Update on Operations 7:01 a.m. May 9, 2014 - GlobeNewswire
Amarin to Report First Quarter 2014 Results and Host Conference Call on May 9, 2014 8:01 a.m. May 5, 2014 - GlobeNewswire
Amarin Announces Presentation of New MARINE and ANCHOR Post-Hoc Analyses at National Lipid Association Annual Scientific Sessions Showing Vascepa(R) Significantly Reduced Apolipoprotein C-III Levels 8:02 a.m. May 2, 2014 - GlobeNewswire
Technical Roundup on Health Care Stocks -- Research on Amarin, United Therapeutics, Hologic, and NxStage Medical 2:10 p.m. April 25, 2014 - PR Newswire - PRF
Amarin Corp. and Kowa Pharmaceuticals to Begin Joint Vascepa Promotion in May 12:25 p.m. April 11, 2014 - ACCESSWIRE
Amarin and Kowa Pharmaceuticals America, Inc. Announce U.S. Co-Promotion Agreement for Vascepa(R) (icosapent ethyl) Capsules 4:37 p.m. March 31, 2014 - GlobeNewswire
Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health 12:19 p.m. March 28, 2014 - PR Newswire - PRF
Amarin Corporation plc. Analyst Report: Special Situation \ Turnaround Opportunity in Biopharmaceuticals - Targeting large existing cardiovascular health market by BrokerBank Securities, Inc. 7:00 a.m. March 28, 2014 - PR Newswire - PRF
Amarin Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Update on Operations 5:14 p.m. Feb. 27, 2014 - GlobeNewswire
Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview 2:59 p.m. Feb. 24, 2014 - PR Newswire - PRF
Amarin to Report Fourth Quarter and Year-End 2013 Results and Host Conference Call on February 27, 2014 7:00 a.m. Feb. 24, 2014 - GlobeNewswire
Amarin Announces FDA Award of Three-Year Exclusivity for Vascepa(R) (icosapent ethyl) Capsules 5:01 p.m. Feb. 21, 2014 - GlobeNewswire
Amarin to Present at the 2014 Leerink Global Healthcare Conference 7:30 a.m. Feb. 6, 2014 - GlobeNewswire
Amarin Announces Promotion of Aaron Berg to Senior Vice President, Marketing and Sales 7:00 a.m. Feb. 4, 2014 - GlobeNewswire
Amarin Announces FDA Review Division Response to ANCHOR SPA Agreement Reinstatement Request 2:00 a.m. Jan. 21, 2014 - GlobeNewswire
Amarin Announces FDA Review Division Response on ANCHOR SPA Agreement Reinstatement Request Will Be Delayed 5:05 p.m. Jan. 15, 2014 - GlobeNewswire
Equity Technical Dimensions:Seattle Genetics, Amarin, and PerkinElmer 9:00 a.m. Dec. 27, 2013 - PR Newswire
New Drug Application Updates, Appointments, Partnership Programs, and Stock Movements - Research Report on Amarin, Oramed Pharmaceuticals, Synta Pharmaceuticals, Healthways and AMN Healthcare 9:00 a.m. Dec. 25, 2013 - PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Amarin Corp. plc and Its Board of Directors and of a Lead Plaintiff Deadline of January 3, 2014 4:29 p.m. Dec. 24, 2013 - PR Newswire
Expedia falls on Google penalty; Alcoa jumps on upgrade 4:54 p.m. Jan. 21, 2014 - Sue Chang
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 5:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Intercept, Celgene on move amid J.P. Morgan event 10:20 a.m. Jan. 13, 2014 - Victor Reklaitis
6 gut checks before the stock market's opening bell 7:12 a.m. July 8, 2013 - Shawn Langlois
6 gut checks before the stock market's opening bell 7:55 a.m. March 27, 2013 - Shawn Langlois
7 gut checks before the stock market's opening bell 8:05 a.m. Feb. 27, 2013 - Shawn Langlois
Friday’s big movers: Groupon soars on Google talk 5:38 p.m. Dec. 7, 2012 - Sue Chang
Amarin down 17% on risks tied to drug launch 9:00 a.m. Dec. 7, 2012 - Steve Gelsi
Amarin down 18% in premarket trades 8:41 a.m. Dec. 7, 2012 - Steve Gelsi
Wednesday’s biggest gaining and declining stocks 4:40 p.m. Oct. 10, 2012 - Sue Chang
Tuesday’s top gaining and declining stocks 4:57 p.m. Sept. 11, 2012 - MarketWatch
Amarin issues patent update on fish-oil drug 12:29 p.m. Sept. 5, 2012 - Val Brickates Kennedy
Amarin jumps 16% after business update 12:06 p.m. Aug. 9, 2012 - Val Brickates Kennedy
Amarin rallies 15% on business update 10:48 a.m. Aug. 9, 2012 - Val Brickates Kennedy
Amarin falls 11% on insider stock-sale reports 12:12 p.m. July 31, 2012 - Val Brickates Kennedy
Amarin, AuthenTec active; advancers outpace decliners 4-1 on NYSE 12:45 p.m. July 27, 2012 - blogs.marketwatch.com
Amarin down 9% in wake of drug approval 10:08 a.m. July 27, 2012 - Val Brickates Kennedy
Amarin gets FDA approval for Vascepa 6:09 p.m. July 26, 2012 - Wallace Witkowski
Amarin: FDA OKs Vascepa for high triglycerides 5:46 p.m. July 26, 2012 - Wallace Witkowski
Amarin halted ahead of FDA decision deadline 3:13 p.m. July 26, 2012 - Val Brickates Kennedy
Top Analyst Upgrades and Downgrades: Amarin, Boeing, Cisco, KKR, NetApp, Twitter and More 8:01 a.m. May 12, 2014 - 247WallSt.com
Amarin's (AMRN) CEO John Thero on Q1 2014 Results - Earnings Call Transcript 12:20 p.m. May 9, 2014 - Seeking Alpha
More on Amarin Q1 results 7:37 a.m. May 9, 2014 - Seeking Alpha
10-Q: AMARIN CORP PLC\UK 7:10 a.m. May 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
Move over Vascepa, here comes Epanova 7:08 a.m. May 6, 2014 - Seeking Alpha
Amarin Takes Step 1, Of A Million, To Right Its Ship 3:21 p.m. April 1, 2014 - Seeking Alpha
Amarin: How The Co-Promotion Agreement With Kowa Affects Required Sales Targets 12:53 a.m. April 1, 2014 - Seeking Alpha
Amarin +4.4% AH on U.S. Vascepa co-promotion deal 5:03 p.m. March 31, 2014 - Seeking Alpha
Looking For Value Among Biotechs After Precipitous Declines In Stock Price 12:26 p.m. March 24, 2014 - Seeking Alpha
Biotech Stock Mailbag: Amarin, Cytrx, Sangamo and 'Story Stocks' 7:00 a.m. March 21, 2014 - TheStreet.com
Are Biotech Stocks Located in Ireland Top Buyout Candidates? 9:34 a.m. March 19, 2014 - 247WallSt.com
Amarin Management Discusses Q4 2013 Results - Earnings Call Transcript 10:20 p.m. Feb. 27, 2014 - Seeking Alpha
10-K: AMARIN CORP PLC\UK 4:14 p.m. Feb. 27, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notable earnings after Thursday’s close 5:35 p.m. Feb. 26, 2014 - Seeking Alpha
Amarin Is Likely Now A Vortex Where Your Money Will Go To Die 2:16 p.m. Feb. 26, 2014 - Seeking Alpha
What Now For Amarin? 2:54 p.m. Feb. 25, 2014 - Seeking Alpha
Amarin's Vascepa Gets 3-Year Exclusivity - Analyst Blog 5:20 p.m. Feb. 24, 2014 - Zacks.com
Amarin fair value target cut at MKM after FDA decision 3:16 p.m. Feb. 24, 2014 - Seeking Alpha
Amarin Loses Bid for Vascepa 5-Year Market Exclusivity 7:59 a.m. Feb. 24, 2014 - TheStreet.com
Amarin's Vascepa given marketing exclusivity, shares +4.8% AH 4:22 p.m. Feb. 21, 2014 - Seeking Alpha
Amarin Announces Private Exchange Transactions Regarding Outstanding Senior Exchangeable Notes 5:00 a.m. Today - GlobeNewswire
Amarin Reports First Quarter 2014 Financial Results and Provides Update on Operations 7:01 a.m. May 9, 2014 - GlobeNewswire
Amarin to Report First Quarter 2014 Results and Host Conference Call on May 9, 2014 8:01 a.m. May 5, 2014 - GlobeNewswire
Amarin Announces Presentation of New MARINE and ANCHOR Post-Hoc Analyses at National Lipid Association Annual Scientific Sessions Showing Vascepa(R) Significantly Reduced Apolipoprotein C-III Levels 8:02 a.m. May 2, 2014 - GlobeNewswire
Technical Roundup on Health Care Stocks -- Research on Amarin, United Therapeutics, Hologic, and NxStage Medical 2:10 p.m. April 25, 2014 - PR Newswire - PRF
Amarin Corp. and Kowa Pharmaceuticals to Begin Joint Vascepa Promotion in May 12:25 p.m. April 11, 2014 - ACCESSWIRE
Amarin and Kowa Pharmaceuticals America, Inc. Announce U.S. Co-Promotion Agreement for Vascepa(R) (icosapent ethyl) Capsules 4:37 p.m. March 31, 2014 - GlobeNewswire
Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health 12:19 p.m. March 28, 2014 - PR Newswire - PRF
Amarin Corporation plc. Analyst Report: Special Situation \ Turnaround Opportunity in Biopharmaceuticals - Targeting large existing cardiovascular health market by BrokerBank Securities, Inc. 7:00 a.m. March 28, 2014 - PR Newswire - PRF
Amarin Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Update on Operations 5:14 p.m. Feb. 27, 2014 - GlobeNewswire
Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview 2:59 p.m. Feb. 24, 2014 - PR Newswire - PRF
Amarin to Report Fourth Quarter and Year-End 2013 Results and Host Conference Call on February 27, 2014 7:00 a.m. Feb. 24, 2014 - GlobeNewswire
Amarin Announces FDA Award of Three-Year Exclusivity for Vascepa(R) (icosapent ethyl) Capsules 5:01 p.m. Feb. 21, 2014 - GlobeNewswire
Amarin to Present at the 2014 Leerink Global Healthcare Conference 7:30 a.m. Feb. 6, 2014 - GlobeNewswire
Amarin Announces Promotion of Aaron Berg to Senior Vice President, Marketing and Sales 7:00 a.m. Feb. 4, 2014 - GlobeNewswire
Amarin Announces FDA Review Division Response to ANCHOR SPA Agreement Reinstatement Request 2:00 a.m. Jan. 21, 2014 - GlobeNewswire
Amarin Announces FDA Review Division Response on ANCHOR SPA Agreement Reinstatement Request Will Be Delayed 5:05 p.m. Jan. 15, 2014 - GlobeNewswire
Equity Technical Dimensions:Seattle Genetics, Amarin, and PerkinElmer 9:00 a.m. Dec. 27, 2013 - PR Newswire
New Drug Application Updates, Appointments, Partnership Programs, and Stock Movements - Research Report on Amarin, Oramed Pharmaceuticals, Synta Pharmaceuticals, Healthways and AMN Healthcare 9:00 a.m. Dec. 25, 2013 - PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Amarin Corp. plc and Its Board of Directors and of a Lead Plaintiff Deadline of January 3, 2014 4:29 p.m. Dec. 24, 2013 - PR Newswire
(0)
(0)